OncoSil Medical (ASX:OSL) has commenced its commercial rollout in Portugal with the successful first treatment using the OncoSil device at Instituto Portugues de Oncologia do Porto Francisco Gentil on Oct. 2, according to a Friday filing with the Australian bourse.
The company will continue partnering with clinicians in Portugal to support OncoSil adoption and expand into new international markets, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.